August 2, 2026
Approximately 5 minutes
Reviewed by Nate Lam, Founder & Director, ElendiLabs
Comparing Medical Device Regulations in Hong Kong and Nigeria: MDACS vs NAFDAC
Quick answer
How do Hong Kong and Nigeria medical device regulations compare?
Hong Kong and Nigeria both use risk-based medical device frameworks, but they differ sharply on legal force and market-entry mechanics. In Hong Kong, the Medical Device Division (MDD) of the Department of Health runs the Medical Device Administrative Control System (MDACS) — a voluntary listing system for Class II / III / IV general medical devices (GMD) and Class B / C / D in vitro diagnostic medical devices (IVDMD). Applications are filed by a Local Responsible Person (LRP) through the Medical Device Information System (MDIS); typical review is about 12 weeks, listing is free of charge, and certificates last 5 years. Class I GMD and Class A IVDMD are outside current MDACS device listing scope. In Nigeria, the National Agency for Food and Drug Administration and Control (NAFDAC) requires mandatory registration before manufacture, import, export, advertisement, sale, distribution, or use, under the NAFDAC Act CAP N1 (LFN) 2004 and the Medical Devices and Related Products Regulations, 2024. Applications run on NAPAMS; foreign manufacturers typically appoint a local applicant with a notarised Power of Attorney. Registration certificates are also valid for 5 years, with class-based processing targets of 120 workdays (Class A) or 240 workdays (Class B–D). Always check the latest MDD and NAFDAC guidance before filing.
Who this applies to
| Role | Why this comparison matters |
|---|---|
| Overseas manufacturers | Deciding whether to prioritise Hong Kong listing, Nigeria registration, or both |
| Hong Kong LRPs | Mapping MDACS Pathway 1 / 2 evidence to products also destined for Nigeria |
| Nigerian applicants / local agents | Understanding how Hong Kong’s voluntary system differs from NAFDAC’s mandatory registration |
| Regulatory affairs / market-access teams | Building dual-market dossiers (classification, QMS, labelling, post-market) |
| Importers and distributors | Aligning trader obligations, import permits, and hospital procurement expectations |
Product scope: general medical devices and IVDs (including related products regulated with medical devices in Nigeria). This article is educational regulatory guidance, not legal advice. Requirements change — verify current MDD and NAFDAC documents before submission.
This comparison focuses more on the Hong Kong MDACS pathway. For deeper practical detail on medical device regulation and market access in Nigeria, readers can refer to PheniPharma.
Hong Kong framework: MDACS in depth
Hong Kong’s medical device controls sit primarily under MDACS, administered by MDD. Per Guidance Note GN-01 and MDD’s MDACS web pages, MDACS combines:
- A listing system for eligible devices and traders (importers, distributors, local manufacturers, LRPs, CABs)
- An adverse event reporting pathway centred on the LRP
MDACS is intentionally administrative and voluntary for device listing. It was designed to raise safety and performance standards while preparing industry for a future statutory regime. In practice, listing is commercially material: healthcare institutions are advised to purchase listed devices where possible, and Department of Health procurement Stage C (effective 23 March 2026) requires that applicable MDs procured by DH — Class II / III / IV GMD and Class B / C / D IVDMD — be MDACS-listed.
Key Hong Kong instruments
| Instrument | Role |
|---|---|
| GN-01 | Overview of MDACS, LRP concept, listing system structure |
| GN-02 | Listing Class II / III / IV general medical devices (form MD101) |
| GN-06 | Listing Class B / C / D IVDMDs (form MD102) |
| TR-003 | Classification rules for GMD (Classes I–IV) |
| TR-006 | Classification rules for IVDMD (Classes A–D) |
| TR-005 | Labelling requirements |
| COP-01 | Code of Practice for Local Responsible Persons |
| MDIS | Electronic submission portal (https://mdis.mdd.gov.hk) |
Classification in Hong Kong
Hong Kong uses separate four-class schemes for GMD and IVDMD, aligned with international risk principles:
| Product type | Lowest risk | Highest risk | Eligible for MDACS device listing? |
|---|---|---|---|
| GMD | Class I | Class IV | Class II, III, IV only |
| IVDMD | Class A | Class D | Class B, C, D only |
Classification depends on intended purpose, duration of contact, invasiveness, active vs non-active characteristics, and (for IVDs) individual and public-health risk. MDD provides online classification tools and Technical References TR-003 / TR-006. Misclassification is a common cause of rejected or delayed MDIS applications because GN-02 / GN-06 only cover in-scope classes.
Who may apply in Hong Kong
Only the Local Responsible Person (LRP) of the device may apply for listing under GN-02 / GN-06. The LRP must be:
- A legal person incorporated in Hong Kong, or
- A natural or legal person with Hong Kong business registration
A manufacturer with a registered place of business in Hong Kong may act as its own LRP or designate another eligible body. An overseas manufacturer must designate an external LRP. If the applicant has no valid LRP listing number, MDIS initiates an LRP application in parallel — device listing cannot proceed until the LRP application is approved.
Hong Kong listing pathways and workflow
MDD’s Overview of Hong Kong Medical Device Listing Process (September 2025) summarises two evidence pathways:
| Pathway | Evidence route | When to use |
|---|---|---|
| Pathway 1 | Conformity Assessment Certificate from an MDD-recognised CAB | Device assessed under MDACS CAB scheme |
| Pathway 2 | Marketing approval documents from recognised jurisdictions: China (NMPA), United States (FDA), European Union, Canada, Japan, Australia, South Korea (MFDS), Singapore (HSA) | Device already approved in a reference market |
Typical Hong Kong listing steps:
- Confirm the product is a medical device / IVDMD under MDACS definitions (GN-00 / GN-01).
- Classify under TR-003 (GMD) or TR-006 (IVDMD). If Class I or Class A, device listing is outside current scope — stop and reassess trader / post-market needs.
- Appoint or confirm the LRP; prepare the manufacturer’s LRP designation letter and Hong Kong Business Registration Certificate.
- Open / use an MDIS account; prepare MD101 (GMD) or MD102 (IVDMD).
- Compile dossier essentials: ISO 13485 (or equivalent), Essential Principles checklist / DoC, clinical evaluation (GMD) or performance evaluation (IVDMD), labelling per TR-005, Pathway 1 CAB certificate or Pathway 2 reference approvals, plus any Cap. 303 radiation-related licences if applicable.
- Submit electronically via MDIS. MDD may take up to 2 weeks to acknowledge and assign an application number (e.g. ANXXXXXX).
- Respond to supplementary information requests on MDIS. Incomplete responses by the deadline can lead to application closure.
- On approval, listing is typically valid 5 years, free of charge. Public listing details appear on MDD’s List of Medical Devices.
Renewals: submit between 12 weeks and 1 year before expiry. Applications filed less than 12 weeks before expiry will not be processed. Major changes need prior approval; minor changes require notification.
Post-market duties of the Hong Kong LRP
After listing, the LRP must handle complaints, report adverse events, manage recalls, and keep records available for MDD inspection. These obligations are core to MDACS even though pre-market listing remains voluntary.
Nigeria framework: NAFDAC registration (comparison focus)
The summary below highlights how Nigeria differs from Hong Kong for dual-market planning. For fuller Nigeria-specific registration, compliance, and market-access detail, see PheniPharma.
Nigeria’s principal regulator for medical devices and IVDs is NAFDAC, with medical device registration handled through the Vaccines, Biologics and Medical Devices Registration and Regulatory Affairs (VBM-R&RA) Directorate. Unlike Hong Kong’s voluntary MDACS listing, Nigeria’s baseline rule is mandatory registration:
No medical device (including IVDs) shall be manufactured, imported, exported, advertised, sold, distributed, or used in Nigeria unless registered under the NAFDAC Act CAP N1 (LFN) 2004, related legislation, and accompanying guidelines.
The NAFDAC Medical Devices and Related Products (Registration, Labelling and Advertisement) Regulations, 2024 set classification, registration, labelling, advertisement, and surveillance rules. Detailed process steps appear in NAFDAC’s Guidelines for Registration of Medical Devices Including In Vitro Diagnostics (IVDs) and Related Products (2025).
Classification in Nigeria
| Device type | Classes (risk ascending) |
|---|---|
| Medical devices and related products | A low → B low–moderate → C moderate–high → D high |
| IVDs | A low individual & public health risk → D high individual & high public health risk |
If a product could fall into more than one class, the higher class applies.
Nigeria registration workflow (summary)
- Dossier screening clearance for moderate/high-risk IVD and non-IVD devices (email
md.vbmrr@nafdac.gov.ngto obtain upload access, per 2025 Guidelines). - Submit a separate application per device, group, family, or system on NAPAMS (https://registration.nafdac.gov.ng).
- Upload administrative and technical documents (see checklist below).
- Obtain electronic Permit to Import registration samples (imported products).
- Complete GMP inspection pathway via Drug Evaluation and Research (DER) requirements.
- Submit samples for laboratory analysis (imported) or have DER draw samples (local manufacture).
- Products proceed to Food and Drug Registration Committee (FDRC) approval meetings after satisfactory documentation, GMP, and lab outcomes (where applicable).
- Successful applications receive a Certificate of Registration valid for 5 years. Advertising requires a separate permit.
Processing targets (2025 Guidelines): Class A — maximum 120 workdays; Classes B, C, D — maximum 240 workdays. The clock stops when a Compliance Directive is issued. Failure to respond to NAFDAC queries within 90 days can close the application.
Side-by-side comparison
| Topic | Hong Kong (MDACS / MDD) | Nigeria (NAFDAC) |
|---|---|---|
| Legal character | Voluntary administrative listing | Mandatory registration before market activities |
| Primary regulator | MDD, Department of Health | NAFDAC (VBM-R&RA) |
| Risk classes (GMD) | Class I–IV | Class A–D |
| Risk classes (IVD) | Class A–D | Class A–D |
| Lowest-risk pre-market | Class I / Class A outside device listing scope | Still generally register unless exempted |
| Local party | LRP (HK incorporation or business registration) | Nigerian applicant with PoA / local corporate documents |
| Portal | MDIS | NAPAMS |
| Evidence shortcuts | Pathway 2 reference approvals (8 jurisdictions) | Reliance / CRP pathways under separate NAFDAC guidelines |
| Gov. listing / registration fee | Free for MDACS listing | Fees per NAFDAC Tariff (pay as directed) |
| Typical timeline | ~12 weeks from complete dossier | 120 (A) / 240 (B–D) workdays |
| Certificate validity | 5 years | 5 years |
| Lab samples | Not the default MDACS gate | Import permit + lab analysis common for imports |
| GMP inspection | Via QMS / CAB / reference evidence; CAB pathway available | Letter inviting overseas GMP inspection often required |
| Advertising | Subject to other HK laws; listing ≠ advertising permit | Separate NAFDAC advertising approval |
| Public procurement signal | DH Stage C: listed MDs required for applicable DH procurement (from 23 Mar 2026) | Registration required for lawful market supply |
Step-by-step: planning both markets
- Inventory intended use and models for each SKU (same intended purpose wording reduces rework).
- Classify twice: TR-003 / TR-006 for Hong Kong; NAFDAC Class A–D rules for Nigeria. Do not assume Class II ≡ Class B.
- Appoint local parties early: Hong Kong LRP agreement (COP-01 obligations); Nigeria Power of Attorney (≥5 years, notarised in country of manufacture) and CAC incorporation evidence.
- Reuse core technical evidence: ISO 13485, Essential Principles / DoC, clinical or performance evaluation, risk management (ISO 14971-aligned), labelling master.
- Localise labels: Hong Kong TR-005 listing information; Nigeria minimum label/IFU elements in the 2025 Guidelines (device name, manufacturer, identifier, lot, sterile/single-use statements, dates, directions, storage, etc.).
- Choose Hong Kong pathway: Pathway 2 if you hold NMPA / FDA / EU / Canada / Japan / TGA / MFDS / HSA approvals covering the exact models; otherwise Pathway 1 CAB.
- Sequence Nigeria docs: Free Sale Certificate authenticated by Nigerian Embassy (or Commonwealth/ECOWAS mission where no Nigerian embassy exists), CoA, trademark evidence, GMP invitation letter, then NAPAMS upload.
- File portals: MDIS for Hong Kong; NAPAMS for Nigeria — never interchange dossiers without adapting forms and declarations.
- Plan renewals on a shared calendar (both certificates typically 5 years; Hong Kong renewals need ≥12 weeks lead time).
- Keep post-market systems ready: Hong Kong LRP vigilance/recall; Nigeria PMS plan aligned with NAFDAC vigilance guidance.
Key documents checklist
Hong Kong (typical MDACS listing file)
- Manufacturer’s letter designating the LRP
- Applicant’s valid Hong Kong Business Registration Certificate
- CAB Conformity Assessment Certificate or Pathway 2 marketing approval documents
- ISO 13485 certificate or equivalent QMS evidence
- Essential Principles Conformity Checklist / Declaration of Conformity
- Clinical Evaluation Report (GMD) or Performance Evaluation Report (IVDMD)
- Device labelling / IFU / manuals (TR-005)
- Any Cap. 303 or other Hong Kong licences if applicable
Nigeria (typical NAFDAC registration file)
- Dossier Screening Clearance (where required)
- Application letter to NAFDAC DG (Attention: VBM-R&RA Director)
- Notarised Declaration (imported products)
- Power of Attorney or Contract Manufacturing Agreement
- Certificate of Manufacture and Free Sale (embassy-authenticated)
- Comprehensive Certificate of Analysis
- CAC business incorporation evidence
- Trademark registration evidence
- Labels/artwork meeting NAFDAC labelling rules
- GMP inspection invitation letter (imports)
- QMS evidence; Declaration of Conformity
- Product dossier ToC for Class C and D (IVD or nIVD as applicable)
Common pitfalls
- Treating Hong Kong listing as optional for hospital sales — MDACS is voluntary in law, but DH Stage C and many buyers expect listing for in-scope classes.
- Assuming Class I/A products need MD101/MD102 — they are outside current device listing scope.
- Assuming Nigeria Class A products need no registration — NAFDAC’s default is registration unless a specific exemption applies.
- LRP vs PoA confusion — Hong Kong needs an LRP with ongoing vigilance duties; Nigeria needs a properly notarised PoA and Nigerian corporate filings.
- Reference approvals that omit models — Pathway 2 certificates must explicitly cover the Hong Kong listing models / codes.
- Unauthenticated Free Sale Certificates for Nigeria — missing embassy/Commonwealth/ECOWAS authentication delays NAPAMS progress.
- Slow query responses — Nigeria may close files after 90 days of silence; Hong Kong may close incomplete MDIS supplements.
- Using registration as advertising approval in Nigeria — advertising needs a separate NAFDAC permit.
- Ignoring renewal lead times in Hong Kong — filing inside the final 12 weeks before expiry is rejected.
- Copying consultancy summaries without checking current PDFs — always prefer MDD/NAFDAC editions on the official sites.
Frequently asked questions
Is MDACS listing mandatory in Hong Kong?
MDACS device listing is voluntary under current administrative controls. However, listing applies only to Class II / III / IV GMD and Class B / C / D IVDMD, and is increasingly expected for public procurement. Since 23 March 2026, DH Stage C requires applicable MDs procured by DH to be MDACS-listed. Confirm class and buyer requirements before relying on “voluntary” status.
Do all medical devices need NAFDAC registration in Nigeria?
As a rule, yes — NAFDAC states that medical devices including IVDs must be registered before manufacture, import, export, advertisement, sale, distribution, or use, unless a specific exemption applies. Check current guidelines and obtain written clarification from NAFDAC when unsure.
How do Hong Kong Class I–IV map to Nigeria Class A–D?
Both systems are four-tier and risk-based, but rules differ. Hong Kong uses I–IV for GMD and A–D for IVDMD under TR-003 / TR-006. Nigeria uses A–D for both medical devices and IVDs under its 2024 Regulations and 2025 Guidelines. Always classify independently for each market.
What is an LRP in Hong Kong versus a Power of Attorney applicant in Nigeria?
A Hong Kong LRP is the MDACS contact who submits MDIS applications and performs post-market duties (complaints, adverse events, recalls, records). A Nigeria applicant for an overseas manufacturer files a Power of Attorney (notarised in the country of manufacture, valid at least five years) authorising registration with NAFDAC, plus local corporate documents.
Which portal do I use — MDIS or NAPAMS?
Use MDIS (https://mdis.mdd.gov.hk) for Hong Kong MDACS listing. Use NAPAMS (https://registration.nafdac.gov.ng) for NAFDAC registration and renewals. They are separate systems with different forms and document sets.
How long do reviews take in each market?
Hong Kong MDD typically aims to complete vetting within 12 weeks after all required information is submitted. Nigeria targets 120 workdays for Class A and 240 workdays for Classes B–D, with the clock paused during compliance directives.
Are there government fees for MDACS listing?
MDD’s Overview states MDACS listing is free of charge. Nigeria charges fees according to the NAFDAC Tariff section referenced in its guidelines.
How long are listing or registration certificates valid?
Both Hong Kong MDACS listing certificates and NAFDAC Certificates of Registration are typically valid for five years, subject to ongoing compliance and timely renewal.
Official sources
- Hong Kong MDD — Medical Device Administrative Control System / MDIS information: https://www.mdd.gov.hk/en/mdacs/mdis/index.html
- Hong Kong MDD — Medical Device Information System (MDIS): https://mdis.mdd.gov.hk
- Hong Kong MDD — Overview of Hong Kong Medical Device Listing Process (PDF, September 2025): https://www.mdd.gov.hk/filemanager/common/information-publication/Overview%20of%20Hong%20Kong%20Medical%20Device%20Listing%20Process.pdf
- Hong Kong MDD — GN-01 Overview of MDACS (PDF): https://www.mdd.gov.hk/filemanager/common/mdacs/GN-01-E.pdf
- Hong Kong MDD — GN-02 Listing Class II / III / IV GMD (PDF): https://www.mdd.gov.hk/filemanager/common/mdacs/GN-02-E.pdf
- Hong Kong MDD — GN-06 Listing Class B / C / D IVDMD (PDF): https://www.mdd.gov.hk/filemanager/common/mdacs/GN-06-E.pdf
- Hong Kong MDD — TR-003 Classification of General Medical Devices (PDF): https://www.mdd.gov.hk/filemanager/common/mdacs/TR003E.pdf
- Hong Kong MDD — TR-006 Classification of IVD Medical Devices (PDF): https://www.mdd.gov.hk/filemanager/common/mdacs/TR006E.pdf
- Hong Kong MDD — TR-005 Labelling (PDF): https://www.mdd.gov.hk/filemanager/common/mdacs/TR005E.pdf
- Hong Kong MDD — COP-01 Code of Practice for LRPs (PDF): https://www.mdd.gov.hk/filemanager/common/mdacs/COP-01E.pdf
- NAFDAC — Guidelines index: https://www.nafdac.gov.ng/regulatory-resources/guidelines/
- NAFDAC — Guidelines for Registration of Medical Devices Including IVDs and Related Products (2025 PDF): https://www.nafdac.gov.ng/wp-content/uploads/Files/Resources/Guidelines/VBM_R&R/2025-2030/Guidelines-for-Registration-of-Medical-Devices-Including-In-Vitro-Diagnostics-IVDs-and-Related-Products.pdf
- NAFDAC — Medical Devices and Related Products Regulations, 2024 (PDF): https://www.nafdac.gov.ng/wp-content/uploads/Files/Resources/Regulations/Medical_Devices/NAFDAC-11-Medical-Device-and-Related-Products-Regulations-2024.pdf
- NAFDAC — NAPAMS portal: https://registration.nafdac.gov.ng
Need Regulatory Help? Try Our Platform
Post your regulatory questions or request quotations from verified pharmaceutical consultants worldwide. Get matched with experts who specialize in your market.
Unbeatable Pricing
Transparent, competitive rates for medical device registration in Hong Kong.
Registered Pharmacist · AI Engineer · Director, ElendiLabs
Registered pharmacist, AI engineer, HKHAIS founder, and pharmaceutical & medical device SEO/GEO specialist.
Ask Anything
We'll follow up with you personally.
100% response rate • Reply within 7 business days
Related Articles
Approximately 5 minutes
Hong Kong MDACS Medical Device Regulations: Framework and Compliance
Understand Hong Kong MDACS medical device regulations, the Department of Health framework, classification, listing, and post-market control for market access.
Approximately 5 minutes
Hong Kong Medical Device Regulations: MDACS Guide
A practical guide to Hong Kong medical device regulations, MDACS classification, listing requirements, local responsibility, and post-market duties.
Approximately 5 minutes
Hong Kong Medical Device Classification: TR-003 Rules
Understand Hong Kong medical device classification under MDACS TR-003, including risk classes, classification factors, and listing implications.
Approximately 5 minutes
Hong Kong MDACS Reference Country Pathway: Accepted Marketing Approvals and GN-06 Requirements
Hong Kong MDACS Pathway 2 accepts marketing approvals from NMPA, FDA, EU, Health Canada, PMDA, TGA, MFDS, and HSA from 2024—GN-02/GN-06 D002 document rules and MDIS submission.
Approximately 5 minutes
Code of Practice for Local Responsible Persons (LRPs) in Hong Kong: A Guide to COP-01
The Local Responsible Person (LRP) is a cornerstone of Hong Kong's Medical Device Administrative Control System (MDACS). This article, guided by Code of Practice COP-01, outlines the extensive responsibilities and duties of LRPs in ensuring the safety, quality, and performance of medical devices throughout their lifecycle, all from our experience and knowledge.